iTestis: Development of a detailed database for collection of clinical data in patients with testicular cancer

Not Applicable

Recruiting

• Conditions: testicular cancer; Cancer - Testicular

• Registration Number: ACTRN12618000735257
• Lead Sponsor: Walter and Eliza Hall Institute for Medical Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-05-02
• Last Update Posted: 9 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 300

Inclusion Criteria

Histologically or cytologically confirmed GCT (non-seminoma or seminoma); or exceptionally raised tumour markers (AFP greater then or equal to 1000ng/mL and/or HCG greater than or equal to 5000 IU/L) without histological or cytological confirmation in the rare case where biopsy may not be feasible.
Primary arising in testis, retro-peritoneum, or mediastinum.

Exclusion Criteria

None

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of patients diagnosed with Germ Cell Tumour (GCT) in Australia that are recurrence-free after treatment. This outcome is being assessed from each patient's medical record,[End of 4 year data collection period. Data will be collected at up to 6 timepoints:<br>Diagnosis<br>Surgery<br>Surveillance<br>Chemotherapy<br>Radiotherapy<br>Recurrence]

Secondary Outcome Measures

Name	Time	Method
Overall survival of patients diagnosed with Germ Cell Tumour (GCT) in Australia after treatment. This outcome is being assessed from each patient's medical record,[End of 4 year data collection period. Data will be collected at up to 6 timepoints:<br>Diagnosis<br>Surgery<br>Surveillance<br>Chemotherapy<br>Radiotherapy<br>Recurrence]